T. Vidmar, L. Freshwater & R. Collins. 2024. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
491
513
.
Lu Mao. (2019) Proportional hazards regression of survival‐sacrifice data with cause‐of‐death information in animal carcinogenicity studies. Statistics in Medicine 38:19, pages 3628-3641.
Crossref
Lu Mao. 2019. Contemporary Biostatistics with Biopharmaceutical Applications. Contemporary Biostatistics with Biopharmaceutical Applications
3
18
.
T. Vidmar, L. Freshwater & R. Collins. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
475
497
.
Gregg E. Dinse. 2014. Wiley StatsRef: Statistics Reference Online. Wiley StatsRef: Statistics Reference Online.
Gregg E. Dinse. 2014. Wiley StatsRef: Statistics Reference Online. Wiley StatsRef: Statistics Reference Online.
A. Dewanji. 2014. Wiley StatsRef: Statistics Reference Online. Wiley StatsRef: Statistics Reference Online.
Tom Vidmar, Les Freshwater & Roger Collins. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development
725
746
.
Vladimir N. Anisimov, Irina G. Popovich & Mark A. Zabezhinski. 2013. Biological Aging. Biological Aging
145
160
.
Gregg E. Dinse. 2001. Encyclopedia of Environmetrics. Encyclopedia of Environmetrics.
. 2010. Drug Safety Evaluation. Drug Safety Evaluation
481
519
.
. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
39
.
Chi‐Ming Chang, Wen‐Chou Lin, Hsu‐Sung Kuo, Ming‐Fang Yen & Tony Hsiu‐Hsi Chen. (2007) Estimation and prediction system for multi‐state disease process: application to analysis of organized screening regime. Journal of Evaluation in Clinical Practice 13:6, pages 867-881.
Crossref
Wonkuk Kim, Hongshik Ahn & Hojin Moon. (2006) A dose–response test via closed‐form solutions for constrained MLEs in survival/sacrifice experiments. Statistics in Medicine 26:3, pages 694-708.
Crossref
Gregg E. Dinse. 2005. Encyclopedia of Biostatistics. Encyclopedia of Biostatistics.
A. Dewanji. 2005. Encyclopedia of Biostatistics. Encyclopedia of Biostatistics.
Shyamal D. Peddada, Gregg E. Dinse & Joseph K. Haseman. (2005) A Survival-Adjusted Quantal Response Test for Comparing Tumour Incidence Rates. Journal of the Royal Statistical Society Series C: Applied Statistics 54:1, pages 51-61.
Crossref
T. Härkänen & E. Arjas. (2004) Tumour Incidence, Prevalence and Lethality Estimation in the Absence of Cause-of-Death Information. Journal of the Royal Statistical Society Series C: Applied Statistics 53:4, pages 601-617.
Crossref
Hojin Moon, Hongshik Ahn & Ralph L. Kodell. (2002) Extension of Peto's Test by Attribution of Tumor Lethality in the Absence of Cause‐of‐Death Information. Biometrical Journal 44:8, pages 982-1001.
Crossref
John D. Kalbfleisch & Ross L. Prentice. 2002. The Statistical Analysis of Failure Time Data. The Statistical Analysis of Failure Time Data
404
427
.
David B. Dunson & Donna D. Baird. (2004) A Proportional Hazards Model for Incidence and Induced Remission of Disease. Biometrics 58:1, pages 71-78.
Crossref
Gregg E. Dinse. 2001. Encyclopedia of Environmetrics. Encyclopedia of Environmetrics.
Hongshik Ahn & Ralph L. Kodell. 2001. Applied Statistics in the Pharmaceutical Industry. Applied Statistics in the Pharmaceutical Industry
43
73
.
Debbie M. Cheng & Stephen W. Lagakos. (2004) The One‐Sample Problem from Eradication Studies of Chronic Viral Infections. Biometrics 56:2, pages 626-633.
Crossref
S. N. Rai, D. E. Matthews & D. R. Krewski. (2008) Mixed‐scale models for survival/sacrifice experiments. Canadian Journal of Statistics 28:1, pages 65-80.
Crossref
Anup Dewanji. 2000. Bioenvironmental and Public Health Statistics. Bioenvironmental and Public Health Statistics
895
911
.
Jianguo Sun. (2004) On the Use of Historical Control Data for Trend Test in Carcinogenicity Studies. Biometrics 55:4, pages 1273-1276.
Crossref
Pierre Joly & Daniel Commenges. (2004) A Penalized Likelihood Approach for a Progressive Three‐State Model with Censored and Truncated Data: Application to AIDS. Biometrics 55:3, pages 887-890.
Crossref
Richard D. Irwin, John E. French, Michael Elwell, Joe Haseman, A. G. Braun & F. A. Voelker. (1999)
Carcinogenicity of dermally administered 1,2‐Dihydro‐2,2,4‐trimethylquinoline monomer in F344 rats and B6C3F
1
mice
. Journal of Applied Toxicology 19:2, pages 123-132.
Crossref
William R. Fairweather, Amit Bhattacharyya, Peter P. Ceuppens, Guenter Heimann, Ludwig A. Hothorn, Ralph L. Kodell, Karl K. Lin, Harry Mager, Brian J. Middleton, Wout Slob, Keith A. Soper, Nigel Stallard, John Ventre & Jane Wright. (1998) Biostatistical Methodology in Carcinogenicity Studies. Drug Information Journal 32:2, pages 401-421.
Crossref
Ralph L. Kodell, Bruce A. Pearce, Angelo Turturro & Hongshik Ahn. (1997) An Age-Adjusted Trend Test for the Tumor Incidence Rate for Single-Sacrifice Experiments. Drug Information Journal 31:2, pages 471-487.
Crossref
Shesh N. Rai. (2007) On Semi‐Parametric Models in Occult Tumour Experiments. Biometrical Journal 39:8, pages 909-918.
Crossref
Nicholas P. Jewell & J. D. Kalbfleisch. (1996) Marker processes in survival analysis. Lifetime Data Analysis 2:1, pages 15-29.
Crossref
N. Stallard & A. Whitehead. (2016) Estimating the magnitude of carcinogenic effects in long-term animal studies. Human & Experimental Toxicology 14:8, pages 643-653.
Crossref
Stephen W. Duffy, Hsiu‐Hsi Chen, Laszlo Tabar & Nicholas E. Day. (2007) Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Statistics in Medicine 14:14, pages 1531-1543.
Crossref
Kevin P. Keenan, Keith A. Soper, Peter F. Smith, Gordon C. Ballam & Robert L. Clark. (2016) Diet, Overfeeding, and Moderate Dietary Restriction in Control Sprague-Dawley Rats: I. Effects on Spontaneous Neoplasms. Toxicologic Pathology 23:3, pages 269-286.
Crossref
S.N. Rai & D.E. Matthews. (2008) The analysis of incomplete data using stochastic covariates. Canadian Journal of Statistics 23:1, pages 29-42.
Crossref
Rumana Z. Omar, Nigel Stallard & John Whitehead. (1995) A parametric multistate model for the analysis of carcinogenicity experiments. Lifetime Data Analysis 1:4, pages 327-346.
Crossref
Hongshik Ahn & Ralph L. Kodell. (2007) Estimation and Testing of Tumor Incidence Rates in Experiments Lacking Cause‐of‐Death Data. Biometrical Journal 37:6, pages 745-763.
Crossref
Alex McMillan, Alice S. Whittemore, Abraham Silvers & Yasamin DiCiccio. (2006)
Use of Biological Markers in Risk Assessment
1
. Risk Analysis 14:5, pages 807-813.
Crossref
Gregg E. Dinse. (2006) A comparison of tumour incidence analyses applicable in single‐sacrifice animal experiments. Statistics in Medicine 13:5-7, pages 689-708.
Crossref
Walter W. Piegorsch. 1994. Environmental Statistics. Environmental Statistics
535
559
.
Walter W. Piegorsch. (2006) Biometrical methods for testing dose effects of environmental stimuli in laboratory studies. Environmetrics 4:4, pages 483-505.
Crossref
Gerald Hajian. (2016) The Whys and Wherefores of Statistics in Carcinogenicity Testing. Drug Information Journal 26:3, pages 361-363.
Crossref
Elja Arjas, Pentti Haara & Sue Leurgans. 1992. Survival Analysis: State of the Art. Survival Analysis: State of the Art
329
344
.
C.‐K. Chou, A. W. Guy, L. L. Kunz, R. B. Johnson, J. J. Crowley & J. H. Krupp. (2005) Long‐term, low‐level microwave irradiation of rats. Bioelectromagnetics 13:6, pages 469-496.
Crossref
O.J.W.F. Kardaun. 1991. Statistical Methods in Biological and Medical Sciences. Statistical Methods in Biological and Medical Sciences
407
459
.
Suresh H. Moolgavkar & Georg Luebeck. (2006) Two‐Event Model for Carcinogenesis: Biological, Mathematical, and Statistical Considerations. Risk Analysis 10:2, pages 323-341.
Crossref
Daniel Krewski & Michael Goddard. (2016) Principles of Bioassay Design. Drug Information Journal 24:2, pages 381-394.
Crossref
N. Brock, B. Schneider, J. Stekar & J. Pohl. (1989) Experimental investigations into the carcinogenic effect of antitumor and immunosuppressive agents. Journal of Cancer Research and Clinical Oncology 115:4, pages 309-328.
Crossref
C.J. Portier. (2016) Life Table Analysis of Carcinogenicity Experiments. Journal of the American College of Toxicology 7:5, pages 575-582.
Crossref
A. John Bailer & Christopher J. Portier. (2006) An illustration of dangers of ignoring survival differences in carcinogenic data. Journal of Applied Toxicology 8:3, pages 185-189.
Crossref
Thomas R. FearsRobert M. Elashoff & Marvin A. Schneiderman. (2017) The Statistical Analysis of a Carcinogen Mixture Experiment. Ii. Carcinogens with Different Target Organs, N-Methyl-N'-Nitro-N-Nitrosoguanidine, N-Butyl-N-(4-Hydroxybutyl)Nitrosamine, Dipentylnitrosamine, and Nitrilotriacetic Acid. Toxicology and Industrial Health 4:2, pages 221-255.
Crossref
J. D. Kalbfleisch & J. F. Lawless. (2006) Likelihood analysis of multi‐state models for disease incidence and mortality. Statistics in Medicine 7:1-2, pages 149-160.
Crossref
Christopher J. Portier & David G. Hoel. (2006)
Issues Concerning the Estimation of the TD
50
. Risk Analysis 7:4, pages 437-447.
Crossref
Ralph L. Kodell. (2007) Utilizing Cause‐of‐Death Information to Estimate Conditional Probabilities of Disease and Death. Biometrical Journal 29:6, pages 689-701.
Crossref
J. Mau. (1986) Nonparametric estimation of the integrated intensity of an unobservable transition in a Markov illness-death process. Stochastic Processes and their Applications 21:2, pages 275-289.
Crossref